Cure Pharmaceutical Holding Corp. — Form D
Cure Pharmaceutical Holding Corp. of OXNARD, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-05. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-04-05
- Form: D
- Accession: 0001477932-18-001682
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Minimum investment: $10K
- Investors: 23
- Date of first sale: 2018-03-20
- Revenue range: $1 - $1,000,000
- SEC file number: 021-309361
Issuer
- Name: Cure Pharmaceutical Holding Corp.
- CIK: 0001643301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1620 BEACON PLACE, OXNARD, CA, 93033
- Phone: 805-824-0410
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| EDWARD MALISKI | Executive Officer | OXNARD, CA |
| Robert Davidson | Director | OXNARD, CA |
| Robert Davidson | Executive Officer | OXNARD, CA |
| John Bell | Director | New South Wales, C3 |
| Alex Katz | Executive Officer | San Francisco, CA |
| Gene Salkind | Director | Shoreham, NY |
| Lauren Chung | Director | New York, NY |
| JOSH HELD | Director | Los Alimitos, CA |
| Anya Goldin | Director | Oxnard, CA |
| Ruben King-Shaw | Director | Oxnard, CA |
| William Yuan | Director | Oxnard, CA |
| Nancy Duitch | Director | Oxnard, CA |
| Mike Redard | Executive Officer | Oxnard, CA |
| Mark Udell | Executive Officer | OXNARD, CA |
| Alan Einstein | Director | Oxnard, CA |
| Charles Berman | Director | Oxnard, CA |
| Jessica Rousset | Executive Officer | Oxnard, CA |
Other filings by this issuer (3)
More